In adults, BRAF-mutated tumors include 60% of melanomas, 60% of thyroid cancers, 15% of colorectal cancers, and 5% to 8% of non–small cell lung cancers, with the most prevalent mutation being BRAFV600E (2). This evidence concerns the gene BRAF and lung cancer.